HMG20B Antikörper (AA 31-50)
Kurzübersicht für HMG20B Antikörper (AA 31-50) (ABIN636227)
Target
Alle HMG20B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 31-50
-
Kreuzreaktivität (Details)
- This antibodys immunogens shares 80 % sequence identity with its Mouse homolog.
-
Aufreinigung
- Affinity chromatography purified
-
Immunogen
- BRAF35 antibody was raised in rabbit using AA 31-50 [KQERGEGPRA GEKGSHEEEP] of the human structural DNA-binding protein BRAF35 as the immunogen.
-
Isotyp
- IgG
-
-
anti-High Mobility Group 20B (HMG20B) (AA 1-109) antibody
HMG20B Reaktivität: Human WB, ELISA, IF, IHC (p) Wirt: Maus Monoclonal 1F6 unconjugated
anti-High Mobility Group 20B (HMG20B) (AA 1-317) antibodyHMG20B Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-High Mobility Group 20B (HMG20B) antibodyHMG20B Reaktivität: Human WB, IP, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-High Mobility Group 20B (HMG20B) (AA 1-317) antibodyHMG20B Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-High Mobility Group 20B (HMG20B) (N-Term) antibodyHMG20B Reaktivität: Human WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-High Mobility Group 20B (HMG20B) (N-Term) antibodyHMG20B Reaktivität: Human WB, IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-High Mobility Group 20B (HMG20B) (N-Term) antibodyHMG20B Reaktivität: Human WB, IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-High Mobility Group 20B (HMG20B) (AA 1-213) antibodyHMG20B Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-High Mobility Group 20B (HMG20B) (AA 27-213) antibodyHMG20B Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-High Mobility Group 20B (HMG20B) (N-Term) antibodyHMG20B Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
-
WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- Lot specific
-
Buffer
- Affinity purified IgG supplied in PBS with 0.02 % NaN3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
- HMG20B (High Mobility Group 20B (HMG20B))
-
Andere Bezeichnung
- BRAF35
-
Hintergrund
- Mutations of the human BRCA2 gene confer susceptibility to breast cancer. A structural DNA binding component has been identified and is designated as BRCA2-Associated Factor 35 (BRAF35). There is a close association of the BRAF35/BRCA2 complex with condensed chromatin coincident with histone H3 phosphorylation. Experimental evidence suggests a role for the BRCA2/BRAF35 complex in the modulation of cell cycle progression.
Target
-
